Sinclair ##s is named among key players in the global dermal fillers market , which is predicted to see a CAGR of 12.6 % growing from $ 4,450 m in 2016.to $ 10,008.4 m by 2023 , according to Market Research Group . The market 's growth is attracting a host of new companies . While the number of males undergoing facial injectable surgery is growing rapidly , women account for ~91 % of the surgeries . Americas , driven by North and Latin America , remains the top market , followed by Europe , dominated by France although the UK is the fastest growing market . AsiaPac is expected to see a CAGR of 10 % whilst growth in MEA is likely to be limited .
Sinclair Pharma is named among key players in the global dermal fillers market, which is predicted to see a CAGR of 12.6% growing from $4,450m in 2016.to $10,008.4m by 2023, according to Market Research Future. The market's growth is attracting a host of new companies. While the number of males undergoing facial injectable surgery is growing rapidly, women account for ~91% of the surgeries. Americas, driven by North and Latin America, remains the top market, followed by Europe, dominated by France although the UK is the fastest growing market. AsiaPac is expected to see a CAGR of 13.1% whilst growth in MEA is likely to be limited.